Association of State Cannabis Legalization With Cannabis Use Disorder and Cannabis Poisoning [0.03%]
大麻合法化与大麻使用障碍和大麻中毒之间的关联性研究
Jayani Jayawardhana,Jialin Hou,Patricia Freeman et al.
Jayani Jayawardhana et al.
Importance: Whether state implementation of medical and recreational cannabis laws is associated with increased cannabis use disorder (CUD) and/or cannabis poisoning among adults is not evident. ...
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?-Reply [0.03%]
疫苗接种真的能减轻COVID-19的精神病学影响吗？——回复评论
Venexia M Walker,Praveetha Patalay,Jonathan A C Sterne
Venexia M Walker
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial [0.03%]
利培酮和舍曲林联合治疗创伤后应激障碍：三期随机临床试验
Lori L Davis,Saloni Behl,Daniel Lee et al.
Lori L Davis et al.
Importance: New pharmacotherapy options are needed for posttraumatic stress disorder (PTSD). Objective: To investigate the efficacy, sa...
Youth Generalized Anxiety and Brain Activation States During Socioemotional Processing [0.03%]
青少年广泛性焦虑障碍与社会情绪加工过程中的大脑激活状态的关系研究
M Catalina Camacho,Rebecca F Schwarzlose,Michael T Perino et al.
M Catalina Camacho et al.
Importance: The brain enters distinct activation states to support differential cognitive and emotional processes, but little is known about how brain activation states differ in youths with clinical anxiety. ...
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19? [0.03%]
疫苗接种真的会减轻COVID-19的精神病学影响吗？
Yaakov Ophir,Yaffa Shir-Raz
Yaakov Ophir
Error in Figure [0.03%]
图中的错误
Published Erratum
JAMA psychiatry. 2024 Dec 11. DOI:10.1001/jamapsychiatry.2024.4165 2024
Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis [0.03%]
注意力缺陷/多动障碍神经反馈的系统回顾和元分析研究
Samuel J Westwood,Pascal-M Aggensteiner,Anna Kaiser et al.
Samuel J Westwood et al.
Importance: Neurofeedback has been proposed for the treatment of attention-deficit/hyperactivity disorder (ADHD) but the efficacy of this intervention remains unclear. ...
Linking Genome-Wide Association Studies to Pharmacological Treatments for Psychiatric Disorders [0.03%]
精神疾病全基因组关联研究与药物治疗之间的联系
Aurina Arnatkeviciute,Alex Fornito,Janette Tong et al.
Aurina Arnatkeviciute et al.
Importance: Large-scale genome-wide association studies (GWAS) should ideally inform the development of pharmacological treatments, but whether GWAS-identified mechanisms of disease liability correspond to the pathophysio...
David T Zhu,Zirui Song,Sneha Kannan et al.
David T Zhu et al.
Treatment Expectancies and Psilocybin vs Escitalopram for Depression [0.03%]
针对抑郁症的治疗预期和裸盖菇素vs艾斯西塔普隆的效果研究
Ethan G Dutcher,Andrew D Krystal
Ethan G Dutcher